← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP, Global Head of R, D Martin Mackay sold $570K of Alexion Pharmaceuticals, Inc.

Sold$570,284
$139.20Price
4,097Shares
−9%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, May 16. Filed Wed, May 18, 4:36 PM ET, after the close. Not investment advice.